the setting of ZnT5 overexpression in HeLa cells, but not in beta cells natively expressing ZnT5 [2] . Furthermore, prior studies by Nicolson et al. in purified primary alpha and beta cells, as well as by us in whole primary islets, showed low levels of Znt5 mRNA (endoding ZnT5) compared with that of Znt8 [3, 4] . It is therefore uncertain whether natively produced ZnT5 really does contribute to a significant extent to Zn transport into nascent vesicles or the Golgi apparatus of beta cells. It is possible that ZnT8 may yet be the main transporter of Zn into nascent immature secretory vesicles in the absence of evidence to the contrary. Huang et al. have previously shown that the presence of Zn facilitates maturation of proinsulin into properly processed mature insulin, at least under certain redox conditions [5] . In contrast to the observations by Wijesekara et al. however, prior work by Nicolson et al. and Lemaire et al. showed unaltered proinsulin to insulin maturation in a global Znt8-knockout mouse model [3, 6] . These conflicting observations may be a result of variations in diet or other environmental conditions. Such a diet-dependent variation would be consistent with prior reports of variations in beta cell function between colonies of Znt8-null mice bred under different dietary conditions [3, 6] , as discussed in a recent review [7] . Alternatively, the continued production of ZnT8 in alpha cells could, theoretically, lead to an alteration of insulin and proinsulin homeostasis in the beta cell-specific Znt8-knockout model. This would presumably occur through one or more of the many, well-known interactions between alpha and beta cells. Given the negligible level of ZnT8 in non-islet cells [8] , production of ZnT8 by non-islet cells is unlikely to contribute to the phenotype.
The reported impaired proinsulin conversion is evidence of a new mechanism underlying impaired beta cell function in the setting of deficient ZnT8 activity. Several groups have previously attempted to address this question. It has been previously reported that neither a change in membrane potential, nor the rate of secretory vesicle exocytosis are the underlying cause of impaired beta cell function [3, 6] . Lemaire at al. excluded a decrease in the rate of exocytosis of secretory granules or in the rate of insulin diffusion into the circulation following its release [6] . We recently reported that a decrease in ZnT8 levels in primary murine islets does not lead to decreased islet cell viability in the presence of normal or supraphysiological ambient Zn levels [4] . This suggests that reduced ZnT8 activity does not lead to a decrease in beta cell tolerance to elevated Zn levels. This provides indirect evidence that an accumulation of toxic levels of Zn in the cytoplasm in the setting of decreased ZnT8 function does not occur to a significant degree. Further studies examining whether increased levels of ambient Zn are able to compensate for partially impaired ZnT8 function would be of great value.
